| 注册
首页|期刊导航|四川中医|化疗后血小板减少的中西医治疗进展

化疗后血小板减少的中西医治疗进展

黄千千 陈思环 史佳 黄珊 林师伟 徐小雯 田梓岳 秦庆广

四川中医2025,Vol.43Issue(11):217-222,6.
四川中医2025,Vol.43Issue(11):217-222,6.DOI:10.26946/j.cnki.1000-3649.sczy.2507080007

化疗后血小板减少的中西医治疗进展

Progress in the treatment of chemotherapy-induced thrombocytopenia by traditional Chinese and Western medicine

黄千千 1陈思环 1史佳 1黄珊 1林师伟 1徐小雯 1田梓岳 1秦庆广1

作者信息

  • 1. 海南省人民医院中医科,海南 海口 570311
  • 折叠

摘要

Abstract

Chemotherapy-induced thrombocytopenia(CIT)is a common complication in tumor treatment,which has adverse effects on the subsequent anti-tumor treatment process and the quality of life of patients.Western medicine treatment for this disease often involves platelet transfusion and the use of platelet generating drugs,but there are problems such as a shortage of platelets and numerous adverse reactions.Traditional Chinese medicine(TCM)holds unique advantages in the syndrome differentiation and treatment of CIT based on the core pathogenesis of"deficiency of the spleen and kidney and insufficiency of essence and blood".Early prevention and timely intervention are of utmost importance for improving the prognosis of CIT.This paper systematically reviews the research progress in the treatment of CIT with both TCM and Western medicine in recent years,aiming to provide references for clinical practice.

关键词

化疗后血小板减少/中医药/西医

Key words

Chemotherapy-induced thrombocytopenia/Traditional Chinese medicine/Western medicine

分类

中医学

引用本文复制引用

黄千千,陈思环,史佳,黄珊,林师伟,徐小雯,田梓岳,秦庆广..化疗后血小板减少的中西医治疗进展[J].四川中医,2025,43(11):217-222,6.

四川中医

1000-3649

访问量0
|
下载量0
段落导航相关论文